An Elusive Butterfly Expands Its Genome Through Fragmentation

Scientists sequenced the Atlas blue butterfly genome for the first time, revealing its 229 chromosome pairs and new insights into butterfly evolution.

Written byAndrea Lius, PhD
| 3 min read
A close-up picture of the Atlas blue butterfly on a flower
Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The Atlas blue butterfly (Polyommatus atlantica), which is native to Morocco and Algeria, is estimated to have about seven times as many chromosomes as most other butterflies and nearly 10 times as many chromosomes as humans.

Scientists have long suspected that P. atlantica carries more chromosomes than other non-polyploid animals (those with no more than two sets of chromosomes), but they had never sequenced the genome of this elusive butterfly species—until now.

“When we set out to start to understand evolution in butterflies, we knew we had to sequence the most extreme, and somewhat mysterious, Atlas blue butterfly,” said Charlotte Wright, an evolutionary biologist at the Wellcome Sanger Institute in a statement.

In a recent study, Wright and her colleagues discovered that P. atlantica boasts a whopping 229 pairs of chromosomes, and this sizable genome likely resulted from its ancestor’s chromosomes fragmenting into small pieces, rather than duplicating.1 The researchers also found that these events of genome fragmentation, also known as fission, likely occurred in the more loosely packed and transcriptionally active parts of the chromosome. Their findings, published in Current Biology, shed light on how the Atlas blue butterfly evolved and provide hints on how it may adapt in the future.

The researchers evaluated the three-dimensional organization of P. atlantica’s genome using a sequencing approach called Hi-C.2 By doing this, they found that the butterfly has 227 pairs of small, equally sized autosomes and two pairs of large sex chromosomes.

The researchers noted that P. atlantica’s autosomes were distinctively smaller compared to those of other butterflies and moths, suggesting that they likely formed via fission events. To test this hypothesis, the team compared P. atlantica’s genome to that of the common blue butterfly, a closely related species that only has 23 pairs of chromosomes. By evaluating both the length and sequence of these chromosomes, the team gathered that indeed, P. atlantica’s large number of small autosomes likely resulted from genome fragmentation, not duplication.

Continue reading below...

Like this story? Sign up for FREE Genetics updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

“Breaking down [of] chromosomes has been seen in other species of butterflies, but not on this level,” said Roger Vila, an evolutionary biologist at the Institute of Evolutionary Biology and coauthor of the study.

Next, the researchers wanted to know if certain parts of the butterfly genome were more prone to fission. To do this, they annotated the genome of a close but evolutionarily older relative of P. atlantica, which represented a pre-fragmentation chromatin landscape, for loosely packed and transcriptionally active (A), densely packed and transcriptionally inactive (B), or intermediate (S) regions. The team found that fragmentation sites were largely enriched in A regions and depleted in B regions, indicating that loosely packed genomic sites likely made the frequent chromosome fission events in P. atlantica possible.

According to Vila, the extent of P. atlantica’s genome fragmentation suggests that there are evolutionary reasons for this process, and scientists can now begin to explore them. Wright agreed, “We can start to investigate what benefits [fission] might have, how it impacts [the Atlas blue butterflies’] ability to adapt to their environment, and whether there are any lessons we can learn from their DNA that might aid conservation in the future.”

Mark Blaxter, an evolutionary geneticist at the Wellcome Sanger Institute and a coauthor of the study, thought that the team's discovery in butterflies may also have implications for human diseases. “Rearranging chromosomes is also seen in human cancer cells, and understanding this process in the Atlas blue butterfly could help find ways to limit or stop this in cancer cells in the future,” he said.

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Related Topics

Meet the Author

  • Image of Andrea Lius.

    Andrea Lius is an intern at The Scientist. She earned her PhD in pharmacology from the University of Washington. Besides science, she also enjoys writing short-form creative nonfiction.

    View Full Profile
Share
You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo